» Articles » PMID: 28071656

ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease

Overview
Specialty Gastroenterology
Date 2017 Jan 11
PMID 28071656
Citations 183
Authors
Affiliations
Soon will be listed here.
Abstract

Recent data suggest that inflammatory bowel disease (IBD) patients do not receive preventive services at the same rate as general medical patients. Patients with IBD often consider their gastroenterologist to be the primary provider of care. To improve the care delivered to IBD patients, health maintenance issues need to be co-managed by both the gastroenterologist and primary care team. Gastroenterologists need to explicitly inform the primary care provider of the unique needs of the IBD patient, especially those on immunomodulators and biologics or being considered for such therapy. In particular, documentation of up to date vaccinations are crucial as IBD patients are often treated with long-term immune-suppressive therapies and may be at increased risk for infections, many of which are preventable with vaccinations. Health maintenance issues addressed in this guideline include identification, safety and appropriate timing of vaccinations, screening for osteoporosis, cervical cancer, melanoma and non-melanoma skin cancer as well as identification of depression and anxiety and smoking cessation. To accomplish these health maintenance goals, coordination between the primary care provider, gastroenterology team and other specialists is necessary.

Citing Articles

Life's Simple 7 and its impact on chronic bowel disorders: a study on constipation and diarrhea in the U.S. adult population.

Sun H, Qi L, Ming Y, Wang W, Hu M Front Med (Lausanne). 2025; 12:1516210.

PMID: 40012973 PMC: 11862994. DOI: 10.3389/fmed.2025.1516210.


Is There Any Association Between Fat Body Mass and Bone Mineral Density in Patients with Crohn's Disease and Ulcerative Colitis?.

Ratajczak-Pawlowska A, Michalak M, Szymczak-Tomczak A, Rychter A, Zawada A, Skoracka K Nutrients. 2025; 17(3).

PMID: 39940324 PMC: 11820439. DOI: 10.3390/nu17030466.


Understanding the therapeutic toolkit for inflammatory bowel disease.

Vieujean S, Jairath V, Peyrin-Biroulet L, Dubinsky M, Iacucci M, Magro F Nat Rev Gastroenterol Hepatol. 2025; .

PMID: 39891014 DOI: 10.1038/s41575-024-01035-7.


Disseminated Chickenpox Following Live Varicella Vaccination in a Crohn's Disease Patient on Combination Immunosuppression.

Solano Q, Uttal S, Higgins P, Berinstein J Case Rep Gastrointest Med. 2025; 2025:6088333.

PMID: 39872708 PMC: 11772060. DOI: 10.1155/crgm/6088333.


Live Typhoid and Yellow Fever Vaccines Administered to a Patient With Ulcerative Colitis on Vedolizumab.

Hegde Y, Hayney M, Caldera F ACG Case Rep J. 2025; 11(10):e01507.

PMID: 39866528 PMC: 11759320. DOI: 10.14309/crj.0000000000001507.


References
1.
Abbas A, Almukhtar R, Loftus Jr E, Lichtenstein G, Khan N . Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort. Am J Gastroenterol. 2014; 109(11):1781-93. DOI: 10.1038/ajg.2014.298. View

2.
Goodhand J, Wahed M, Mawdsley J, Farmer A, Aziz Q, Rampton D . Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis. 2012; 18(12):2301-9. DOI: 10.1002/ibd.22916. View

3.
Ariyaratnam J, Subramanian V . Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2014; 109(2):163-9. DOI: 10.1038/ajg.2013.451. View

4.
Jung Y, Park J, Kim H, Cho Y, Sohn C, Jeon W . Insufficient knowledge of korean gastroenterologists regarding the vaccination of patients with inflammatory bowel disease. Gut Liver. 2014; 8(3):242-7. PMC: 4026640. DOI: 10.5009/gnl.2014.8.3.242. View

5.
Rahier J, Moreels T, De Munter P, DHaens G . Prevention of opportunistic infections in patients with inflammatory bowel disease and implications of the ECCO consensus in Belgium. Acta Gastroenterol Belg. 2010; 73(1):41-5. View